Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself
11.11.19 | Uri Tal-Tene
This site uses cookies to ensure the best viewing experience for our readers.
Generics
6 stories about Generics
Mylan Cuts Price of Generic Copaxone Offering by 60%
11.07.18 | Lilach Baumer
Teva to Relocate U.S. Headquarters to New Jersey
08.07.18 | Lilach Baumer
Goldman Sachs Sees 16% Upside in Teva Stock
26.06.18 | Dror Reich
In Protest of New Bonus Plan, Teva Sued by Israeli Employees
15.03.18 | Dror Reich
Drugmaker Hikma Appoints Former Teva Executive as CEO
20.02.18 | Asaf Shalev
Tag does not exist. Please try again.